Sales lost to lax pill-taking amount to $564B worldwide, study says

Tools

The pharma industry could add a whopping $564 billion per year to global sales if patients stuck to their drug regimens as prescribed, Capgemini consultants figure, based on estimates of $188 billion lost to poor adherence in the U.S. Report